Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 1 of 45 PageID: 16363
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 2 of 45 PageID: 16364
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 3 of 45 PageID: 16365
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 4 of 45 PageID: 16366
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 5 of 45 PageID: 16367
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 6 of 45 PageID: 16368
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 7 of 45 PageID: 16369
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 8 of 45 PageID: 16370
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 9 of 45 PageID: 16371
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 10 of 45 PageID: 16372
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 11 of 45 PageID: 16373
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 12 of 45 PageID: 16374
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 13 of 45 PageID: 16375
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 14 of 45 PageID: 16376
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 15 of 45 PageID: 16377
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 16 of 45 PageID: 16378
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 17 of 45 PageID: 16379
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 18 of 45 PageID: 16380
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 19 of 45 PageID: 16381
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 20 of 45 PageID: 16382
Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 21 of 45 PageID: 16383
 

 EXHIBIT 1

PHILIP BRADFORD NELSON 

Office Address 

Economists Incorporated 

2121 K Street, NW, Suite 1100 

Washington, DC 20037

(202) 223-4700 

Fax: 202-296-7138 

nelson.p@ei.com 

Education 

Ph.D., Economics 

Yale University, 1980 

A.B., Mathematics & Social Sciences 

Dartmouth College, 1973 

M.A., M. Phil., Economics 

Yale University, 1975, 1977 

Professional Experience 

1987 – Present, Economists Incorporated 

 Principal 

 Senior Vice President 

 Senior Economist 

1999 – 2000, Adjunct Professor, Fordham Law School 

1978 – 1987, Economist, Federal Trade Commission 

 Economic Advisor to Commissioner Calvani 

 Assistant Director for Competition Analysis 

 Deputy Assistant Director for Economic Evidence 

1975 – 1977, Acting Instructor, Yale University 

1974 – 1976, Consultant, Urban Institute 

Professional Awards 

FTC Certificate for “Meritorious Service”

FTC Certificate for “Superior Service”

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 22 of 45 PageID: 16384
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 2

Academic Awards 

Yale University Fellowship 

Sloan Foundation Grant (through Yale Economics Department) 

Phi Beta Kappa (Dartmouth) 

Awarded A.B. with Highest Distinction in Major Field 

Publications 

BOOKS: 

Corporations in Crisis: Behavioral Observations for Bankruptcy Policy, Praeger 

Press, 1981. 

U.S. International Competitiveness, Praeger Press, 1988 (with John Hilke). 

Market Power Handbook: Competition Law and Economic Foundations, ABA 

Antitrust Section, 2005 (editor, with others). 

ARTICLES/REPORTS:

“Contracts Between a Firm and Its Constituents During Bankruptcy Crises,”

Journal of Economic Issues, 1979. 

“Antitrust Policy and the Market Concentration Doctrine: A Reply,” Business 

Economics, 1981 (with John Hilke). 

“Noisy Advertising and the Predation Rule in Antitrust Analysis,” American 

Economic Review, 1984 (with John Hilke). 

“Antitrust Policy and Intra-Industry Direct Foreign Investment: Cause and 

Effect,” in Asim Erdilek (ed.), Multinationals as Mutual Invaders: Intra-Industry 

Direct Foreign Investment, Croom Helm, 1985 (with Louis Silvia). 

“Caveat Innovator: Strategic and Structural Characteristics of New Product

Introductions,” Journal of Economic Behavior and Organization, 1987 (with John 

Hilke). 

“Diversification and Predation,” Journal of Industrial Economics, 1988 (with 

John Hilke). 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 23 of 45 PageID: 16385
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 3

Publications (continued) 

“Geographic Market Definition in an International Context,” Kent–Chicago Law 

Review, 1988 (with George Hay and John Hilke). 

“Nonprice Predation and Attempted Monopolization: The Coffee (General Foods) 

Case,” in John Kwoka and Larry White (eds.), The Antitrust Revolution, Scott, 

Foresman and Company, 1989 (with John Hilke). 

“An Empirical Note from Case Documents on the Economies of Network

Television Advertising,” Review of Industrial Organization, 1989 (with John 

Hilke). 

“The Antitrust Authorities’ Treatment of Imports in Merger Analysis,”

International Merger Law, 1991. 

“Reading Their Lips: Changes In Antitrust Policy Under The Bush

Administration,” Antitrust Bulletin, 1991. 

“Retail Featuring as a Strategic Entry or Mobility Barrier,” International Journal 

of Industrial Organization, 1991 (with John Hilke). 

“A Simultaneous Equations Model of Coffee Brand Pricing and Advertising,”

Review of Economics and Statistics, 1992 (with John Siegfried and John Howell.) 

“The Economics of Entry Lags: A Theoretical and Empirical Overview,”

Antitrust Law Journal, 1993 (with John Hilke). 

“An Antitrust Analysis of the Alliant Decision and Defense Industry Mergers,”

International Merger Law, 1993 (with John Preston). 

“Clinton Administration Brings Changes to Economics and Economists at the

Antitrust Division,” Antitrust, 1994. 

“Damages from Exclusionary Practices,” in Section of Antitrust Law, American 

Bar Association’s, Proving Antitrust Damages, 1996 (with Ann Jones and Roger 

Blair). 

“Comments on Greene, Marvel, and Owen papers at WEA Meetings,” The 

Antitrust Bulletin, 1996. 

“Defense Industry Rationalization: Lockheed Martin (1995),” in John Kwoka and 

Larry White (eds.), The Antitrust Revolution, 1999 (with Robert Stoner). 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 24 of 45 PageID: 16386
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 4

Publications (continued) 

“Consumer Savings from Merger Enforcement: A Review of the Antitrust 

Agencies’ Estimates,” Antitrust, 2001. 

“Consumer Savings from Merger Enforcement: A Review of the Antitrust

Agencies’ Estimates,” Antitrust Law Journal, 2002 (with Su Sun). 

The Economics of Innovation: A Survey, ABA Taskforce Report, 2002 (chair, 

with others). 

“Economists’ Analysis: The European Union’s New Horizontal Merger

Guidelines,” Antitrust, 2003 (with Simon Baker, Simon Bishop, and Derek 

Ridyard). 

“Economists’ Roundtable,” Antitrust, 2003 (with Dennis Carlton, Janusz Ordover, 

and Jonathan Baker). 

“The Implications of Robert Steiner’s Work for Merger Analysis,” The Antitrust 

Bulletin, 2004 (with Gloria Hurdle and Tessie Su). 

“The Use of Econometrics In Class Certification,” American Bar Association’s

Econometrics: Legal, Practical, and Technical Issues, 2005 (with Henry 

McFarland and David Smith). 

“Geographic Market Definition In Markets with Imports: Evolution of Antitrust

Agency Analysis,” The Threshold, 2007. 

“Patent Pools: An Economic Assessment of Current Law and Policy,” Rutgers 

Law Journal, 2007. 

“The Antitrust Economics of Intellectual Property,” American Bar Association’s

Intellectual Property Antitrust Handbook, 2007 (with Robert Stoner). 

“Failing Firms and Declining Industries,” American Bar Association’s Issues in 

Competition Law and Policy, 2008 (with Henry McFarland). 

“The Economic Rationale for Antimonopoly Law and Policy,” American Bar

Association’s, Monopolization and Dominance Handbook, 2011 (with Robert 

Stoner). 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 25 of 45 PageID: 16387
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 5

Professional Activities 

Co-chair, Health Care and Pharmaceuticals Committee, Antitrust Section, 

American Bar Association (2013-Current) 

Vice Chair, Health Care and Pharmaceuticals Committee, Antitrust Section, 

American Bar Association (2006-2013) 

Vice Chair, Intellectual Property Committee, Antitrust Section, American Bar 

Association (2002-2005) 

Chair, Economics Committee, Antitrust Section, American Bar Association 

(1999-2002) 

 Vice Chair, Economics Committee, Antitrust Section, American Bar Association 

(1996-1999) 

Member, American Economics Association 

Other Professional Activities

Referee for Journal of Conflict Resolution 

Referee for Journal of Industrial Economics

Referee for Economic Inquiry

Referee for American Economic Review 

Referee for Economic Development Quarterly

Referee for Review of Economics and Statistics 

Invited Testimony 

Testimony on “Market Definition, Market Power, and Entry in Light of Global 

Competition,” at FTC Hearings on Competition and Consumer Protection Policy

in the New High-Tech, Global Marketplace, October 19, 1995. 

Testimony on “Competition and Innovation: Relationships Between Market 

Structure and Innovation,” at FTC/DOJ Hearings on Competition and Intellectual

Property Law and Policy in the Knowledge-Based Economy, February 20, 2002. 

Testimony on “Monopoly Power, Market Definition, and the Cellophone

Fallacy,” at FTC/DOJ Hearings on Section 2 of the Sherman Act: Single-Firm 

Conduct As Related to Competition, March 7, 2007. 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 26 of 45 PageID: 16388
Curriculum Vitæ

Philip Bradford Nelson

pg. 6

Testimony

AT FTC:

Testified in FTC v. General Foods case. Served on FTC Merger Screening 

Committee. Supervised the economic effort for more than 100 FTC antitrust 

investigations and litigation efforts in the following industries: petroleum, nonpetroleum natural resources, automobile, records, chemicals, consumer products, 

professions and high technology. Also supervised economic work on FTC 

compliance matters, review of HSR guidelines, standard setting organizations and 

international antitrust matters.

AT ECONOMISTS INCORPORATED:

Antitrust matters have involved merger, joint venture, dealer termination, price 

discrimination, intellectual property, predation, class certification, damages, 

attempted monopolization, collusion and monopolization issues. Analyzed 

competition for European acquisitions using EU Merger standards. Analyzed 

competition issues and damages related to patent rights.

Worked on a variety of non-antitrust matters involving damages, transfer pricing, 

dumping, FIFRA, lender liability, Lanham Act and breach of contact. Evaluated 

transfer prices used by foreign corporations with U.S. subsidiary. Analyzed crude 

oil and natural gas issues for FERC hearings.

Testified in:

 Lunkenheimer v. Tomkins 

 GB Biosciences Corporation v. Nations AG II, LLC

 Car Preservation Centers of Ohio et al. v. Ziebart International 

Corporation et al.

 BASF Corporation v. Makhteshim–Agan of North America

 Braintree Laboratories, Inc. v. Schwarz Pharma, Inc.

 Syngenta Crop Protection, Inc. v. Drexel Chemical Company

 In re: Outsidewall Tire Litigation.

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 27 of 45 PageID: 16389
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 7

Testimony (continued) 

Provided only deposition testimony in: 

 Hoover Color Corporation v. Bayer Corporation 

 Allied Signal Inc. et al. v. B.F. Goodrich Co. et al. 

 MacDunnah’s Inc. d/b/a The Fiddlehead Restaurant and the State of

Alaska v. Amerigas Propane, Inc. 

 ChoiceParts, LLC v. General Motors Corporation, Daimler Chrysler 

Corporation, Ford Motor Company, and OEConnection, LLC 

 Matsushita Electric Industrial Co., Ltd. v. Cinram International, Inc 

 Sussex Commons Outlets, LLC v. Chelsea Property Group, Inc., CPG 

Partners, L.P. and John Does 1-10 

 The Research Foundation of State University of New York; Galderma 

Laboratories; and Galderma Laboratories L.P., v. Mylan 

Pharmaceuticals Inc.

 Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. 

and Mylan Inc 

 Thermal Design, Inc. v. American Society of Heating, Refrigerating and 

Air-Conditioning Engineers, Inc. 

 Abbott Laboratories and Fournier Laboratories Ireland, Ltd. v. Impax 

Laboratories, Inc.; Lupin Ltd. and Lupin Pharmaceuticals, Inc.;Mylan 

Pharmaceuticals, Inc. and Mylan, Inc.; Watson Laboratories, Inc.-

Florida, Watson Pharma, Inc., and Watson Pharmaceuticals, Inc.; 

Actavis Elizabeth, LLC. and Actavis, Inc.; Anchen Pharmaceuticals, Inc. 

 Noven Pharmaceuticals, Inc. v. Watson Laboratories, Inc. and Watson 

Pharmaceuticals, Inc. 

 Warner Chilcott Laboratories Ireland Limited; Warner Chilcott Company, 

Inc.; Warner Chilcott (US), LLC; Mayne Pharma International PTY, Ltd 

v. Mylan Pharmaceuticals Inc. and Mylan Inc. 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 28 of 45 PageID: 16390
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 8

Testimony (continued) 

Submitted affidavits/declarations in a number of matters where didn’t testify

including: 

 Mylan Pharmaceuticals, Inc., Rochester Drug Co-Operative, Inc., Meijer, 

Inc., Meijer Distribution, Inc., American Sales Company, LLC, and 

International Brotherhood of Electrical Workers Local 38, Health and 

Welfare Fund v. Warner Chilcott Public Limited Company, et al.

 AstraZeneca LP and AstraZeneca AB v. Breath Limited et al. 

 Valeant International (Barbados) SRL v. Paddock Laboratories LLC

 Jetaway Aviation, LLC v. The Board of County Commissioners of the 

County of Montrose, Colorado; Montrose County Building Authority; Jet 

Center Partners, LLC; Black Canyon Jet Center LLC; William Patterson; 

Kevin Egan; and James Rumble 

 Galderma Laboratories; and Galderma Laboratories L.P., v. Mylan 

Pharmaceuticals Inc 

 In re: Puerto Rico Cabotage 

 The Commissioner of Competition v. Labatt Brewing Company Ltd., 

Lakeport Brewing Ltd., et al. 

 Antimonopoly v. Hasbro, Toys “R” Us, Inc. and Kmart Corporation 

 Little Caesar Enterprises, Inc. v. Gary G. Smith, et al. 

 Royalty payment investigation of North Antelope by the Department of 

Interior. 

Selected Case Experience

Among the matters I have worked on are: 

 W.H. Hunt, et al. v. Bankers Trust Company, et al. (oil refining, drilling 

rigs, bank lending) 

 Cards & Gifts, et al. v. Hallmark Cards, Inc. (greeting cards) 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 29 of 45 PageID: 16391
Curriculum Vitæ

Philip Bradford Nelson

pg. 9

Selected Case Experience (continued)

 Hartford House, Ltd. et al. v. Hallmark Cards, Inc. (greeting cards)

 Hanna-Day International Merger (rubber and plastics)

 McNeilus-Challenge Cook Merger (concrete mixers)

 GE-Union Carbide Silicones Joint Venture (chemicals)

 Saudi Aramco-Texaco Joint Venture (refining and marketing of petroleum 

products)

 McNeilus (ready-mix)

 Clark Equipment-Dexel Industries Merger (forklift trucks)

 MCI-Telecom* USA Merger (telephone transmission)

 Nippon Sheet Glass -Libbey-Owens-Ford Merger (float glass)

 Cement ITC Dumping Case

 Camera ITC Dumping Case

 Imperial Cup-Continental Bondware Merger (paper cups)

 The People of California v. Chevron et al. (oil, pipelines)

 Chemionics v. Guthrie (latex)

 Phibro DOE Filing (oil)

 Hasbro-Tonka Merger (toys)

 Schneider-Square D Merger (electrical controls and distribution 

equipment)

 Giddings & Lewis-Cross & Trecker Merger (machine tools)

 Textron-Cessna Merger (corporate jets)

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 30 of 45 PageID: 16392
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 10

Selected Case Experience (continued) 

 Page-Butler (fixed base operations for servicing planes) 

 Hughes-General Dynamics Merger (missiles) 

 McNeilus-Challenge Cook Merger (concrete mixers) 

 Lockheed-General Dynamics Merger (jet fighters) 

 Durr-Fillauer-Bergen Brunswig Merger (drug wholesaling) 

 Cox Cable-Jones Intercable Merger (San Diego area cable television) 

 Blade Communications Pittsburgh Post-Gazette-Pittsburgh Press Merger 

(newspapers) 

 Lunkenheimer v. Tomkins (valves) 

 Corning-Damon Merger (medical testing labs) 

 Menasha (Poly-Hi)-Solidur Merger (plastic products) 

 SCI-Pierce Brothers Merger (funeral homes) 

 North Antelope Mine filing with Department of Interior (coal) 

 Sunshine v. Vanguard (cellular telephones) 

 Hamilton Testing Service - SDI Merger (emissions testing) 

 Entergy-Gulf States Utilities Merger (electrical utilities) 

 Carmen Santiago v. The Sherwin-Williams Company et al. (paint) 

 Corning Labs’ acquisition of Nichols (laboratory testing) 

 SONAT Gas Inventory Charge filing at FERC (natural gas) 

 Cimarron Pipeline Construction Inc. et al. v. National Council on 

Compensation Insurance, Aberdeen Insurance Company et al. (insurance)

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 31 of 45 PageID: 16393
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 11

Selected Case Experience (continued) 

 AntiMonopoly, Inc. v. Hasbro, Inc., Toys “R” Us, Inc., and K Mart 

Corporation (toys) 

 Mattel-Fischer Price Merger (toys) 

 Dresser-Baroid Merger (oil field services and products) 

 NORAM’s acquisition of Trans Ark assets (natural gas)

 Martin Marietta’s purchase of General Dynamic’s launch vehicle business

(defense) 

 Sky Chefs - Caterair Merger (airline catering) 

 Lockheed - Martin Marietta Merger (defense) 

 Beacon-Pillowtex Merger (blankets) 

 British Telecom’s acquisition of an interest in MCI (telecommunications) 

 CDG v. Genesys (software) 

 Litton’s acquisition of IMO (defense) 

 Little Caesar Enterprises, Inc. v. Gary G. Smith, et al. (fast food 

franchising) 

 Ciba-Geigy’s merger with Sandoz to form Novartis (pharmaceuticals,

animal health, herbicides, gene therapy) 

 Raytheon’s acquisition of Hughes and Texas Instruments (defense) 

 Mattel’s acquisition of Tyco (toys)

 Oshkosh’s acquisition of McNeilus (concrete mixers)

 American Pacific’s acquisition of Kerr McGee ammonium perchlorate 

assets (rocket fuel) 

 PPG’s acquisition of BASF coating assets (coatings)

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 32 of 45 PageID: 16394
Curriculum Vitæ 

Philip Bradford Nelson 

pg. 12

Selected Case Experience (continued) 

 Tosco’s acquisition of Unocal assets (refining, gasoline marketing) 

 USA Waste’s acquisition of Sanifill (refuse collection and disposal) 

 USA Waste’s acquisition of United Waste (refuse collection and disposal)

 Glaxo Wellcome Inc., and Glaxo Group Limited v. Mylan 

Pharmaceuticals Inc. (pharmaceutical patent) 

 Hoffman -La Roche v. Organon Technika (gene therapy patent) 

 Hoover Color Corporation v. Bayer Corporation (pigments) 

 In Re: Brand Name Prescription Drugs Antitrust Litigation 

(pharmaceuticals) 

 Shaw Carpets acquisition of Queen (carpets) 

 El Paso’s acquisition of DeepTech and Sonat (natural gas)

 NOVA acquisition of TransCanada (natural gas) 

 Allied Signal Inc. et al. v. B.F. Goodrich Co. et al. (landing gear systems) 

 MacDunnah’s Inc. d/b/a Fiddlehead Restaurant and the State of Alaska v.

Amerigas Propane, Inc. (propane)

 Commerce Department dumping investigation involving Saudi Arabia, 

Venezuela, Mexico and Iraq (oil)

 Exxon – Mobil merger (refining, gasoline marketing, chemicals) 

 El Paso - Costal merger (natural gas pipelines) 

 El Paso - PG&E acquisition (natural gas pipelines) 

 NASDAQ - AMEX merger (financial market) 

 Pepsi v. Coca-Cola (soft drinks) 

 Valero – UDS merger (refining, gasoline marketing, product pipelines) 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 33 of 45 PageID: 16395
Curriculum Vitæ

Philip Bradford Nelson

pg. 13

Selected Case Experience (continued)

 ChoiceParts, LLC v. General Motors Corporation, Daimler Chrysler 

Corporation, Ford Motor Company, and OEConnection, LLC (auto parts 

B2B software)

 Alcoa/Reynolds (aluminum)

 GB BioSciences Corporation v. Nations AG II, LLC (arbitration hearing, 

pesticide data compensation under FIFRA)

 Matsushita Electric Industrial Co., Ltd. v. Cinram International Inc. 

(DVD patent pool)

 Car Preservation Centers of Ohio et al. v. Ziebart et al. (automotive 

services franchising)

 Sunoco/El Paso Eagle Point Refinery acquisition (oil refining)

 Teva/Sicor asset acquisition (pharmaceuticals)

 Pentair/Wicor (pumps, swimming pool equipment, filters, fabricated 

tanks)

 Apogent/Fisher Scientific (lab equipment)

 Medtronic Sofamar Denek Inc. v. Gary Michelson, M.D., and Karlin 

Technology, Inc. (and counterclaim) (licensing of spine technology patents)

 Gulf Terra/Enterprise (natural gas pipeline, fractionation, ethane, propane)

 Cemex/RMC (cement, ready-mix, aggregate)

 NYSE/Archipelago (financial markets)

 KCP (KIK)/APG (aerosols)

 Braintree Laboratories, Inc. v. Schwarz Pharma, Inc. (MiraLAX, 

polyethylene glycol)

 BASF Corporation v. Makhteshim – Agan of North America

(pendimethalin pesticide)

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 34 of 45 PageID: 16396
Curriculum Vitæ

Philip Bradford Nelson

pg. 14

Selected Case Experience (continued)

 Whirlpool/Maytag (appliances)

 Anadarko/Kerr McGee (natural gas, natural gas pipelines)

 Anadarko/Western (natural gas, natural gas pipelines)

 Thermo Electron/Fisher Scientific (lab equipment)

 Stiefel/Connectics (pharmaceuticals)

 Menasha (ORBIS)/LINPAC (packaging products /containers)

 Sussex Commons Outlets, LLC v. Chelsea Property Group, Inc., CPG 

Partners, L.P. and John Does 1-10 (outlet shopping malls)

 Movie Gallery/Hollywood Video (video rentals)

 Enterprise/Vanguard (car rental)

 Qiagen/Digene (sample and assays technologies)

 Quanta/InfraSource (electrical construction)

 Vallourec/Grant Prideco (steel/OCTG assets)

 In Re: Puerto Rico Cabotage (for Trailer Bridge shipping)

 Pentair/GE (filtration JV)

 Syngenta Crop Protection, Inc. v. Drexel Chemical Company (atrazine)

 The Research Foundation of State University of New York; Galderma 

Laboratories; and Galderma Laboratories L.P., v. Mylan 

Pharmaceuticals Inc. (Oracea, doxycycline)

 In Re: Outsidewall Tire Litigation (mining tires)

 Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. 

and Mylan Inc. (Lescol, fluvastatin)

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 35 of 45 PageID: 16397
Curriculum Vitæ

Philip Bradford Nelson

pg. 15

Selected Case Experience (continued)

 Jetaway Aviation, LLC v. The Board of County Commissioners of the 

County of Montrose, Colorado; Montrose County Building Authority; Jet 

Center Partners, LLC; Black Canyon Jet Center LLC; William Patterson; 

Kevin Egan; and James Rumble (Fixed based operator) 

 Warner Chilcott Laboratories Ireland Limited; Warner Chilcott Company, 

Inc.; Warner Chilcott (US), LLC; and Mayne Pharma International PTY, 

Ltd v. Mylan Pharmaceuticals Inc. and Mylan Inc. (Doryx, doxycycline 

hyclate)

 Regal Beloit/AO Smith Division (electric motors)

 Abbott Laboratories and Fournier Laboratories Ireland, Ltd. v. Impax 

Laboratories, Inc.; Lupin Ltd. and Lupin Pharmaceuticals, Inc.; Mylan 

Pharmaceuticals, Inc. and Mylan, Inc.; Watson Laboratories, Inc.-

Florida, Watson Pharma, Inc., and Watson Pharmaceuticals, Inc.; Actavis 

Elizabeth, LLC. and Actavis, Inc.; Anchen Pharmaceuticals, Inc. (Trilipix, 

fenofibric acid, and dyslipidemia)

 Valeant International (Barbados) SRL v. Paddock Laboratories LLC; 

(Aplenzin (follow-on to Wellbutrin XL), bupropion hydrobromide)

 AmeriGas/Heritage (propane)

 Thermal Design, Inc. v. American Society of Heating, Refrigerating and 

Air-Conditioning Engineers, Inc. (standard setting, insulation)

 Cameco/NUKEM (uranium)

 AstraZeneca LP and AstraZeneca AB v. Breath Limited et al.(Pulmicort 

Respules, budesonide)

 Noven Pharmaceuticals, Inc. v. Watson Laboratories, Inc. and Watson 

Pharmaceuticals, Inc. (Daytrana, Methylphenidate transdermal patches)

 Mylan Pharmaceuticals, Inc., Rochester Drug Co-Operative, Inc., Meijer, 

Inc., Meijer Distribution, Inc., American Sales Company, LLC, and 

International Brotherhood of Electrical Workers Local 38, Health and 

Welfare Fund v. Warner Chilcott Public Limited Company, et al. (Doryx, 

doxycycline hyclate)

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 36 of 45 PageID: 16398
Exhibit 2: Materials Considered 

1 

Legal Documents 

[Proposed] Order Granting Preliminary Injunction Against Defendants Hanmi Usa, Inc., Hanmi 

Pharmaceutical Co., Ltd., Hanmi Fine Chemical Co., Ltd, And Hanmi Holdings Co., Ltd. 

[Proposed] Order Granting Temporary Restraining Order Against Defendants Hanmi Usa, Inc., 

Hanmi Pharmaceutical Co., Ltd., Hanmi Fine Chemical Co., Ltd, And Hanmi Holdings Co., Ltd. 

AstraZeneca’s Memorandum of Points and Authorities in Support of Plaintiffs’ Motion for 

Injunction Pending Appeal 

Complaint for Patent Infringment and Certification Pursuant to Local Rule 11.2 in AstraZeneca 

v. Hanmi 

Complaint in Pfizer v. FDA, Mark McClellan and Tommy Thompson 

Memorandum Of Points And Authorities In Support Of Plaintiffs’ Motion For Injunction 

Pending Appeal 

Memorandum Opinion Of Bongiovanni, Magistrate Judge In Astrazeneca V. Hanmi 

Notice Of Plaintiff’s Motion For Injunction Pending Appeal 

Settlement Agreement between AstraZeneca, KBI, Amneal and Hanmi, USA, May 21, 2013 

U.S. Patent No. 5,714,504 

U.S. Patent No. 5,877,192 

Data 

2001 - 2007 NSP Paxil Pexeva 082713.xls 

Aged Dat Data Mikhail Amneal 2 Current 2008-2013.xls 

Aged Data Mikhail Amneal 1 Current 2008-2013.xls 

Aged Data Mikhail Amneal 3 Current 2008-2013.xls 

Aged Data Mikhail Amneal 4 Current 2008-2013.xls 

NPA_Amneal 1 Aged 2001-2007 082213.xls 

NSP Amneal 3 2001-2007.xls 

NSP_Amneal 1 082213 2001-2007.xlsx 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 37 of 45 PageID: 16399
Exhibit 2: Materials Considered 

2 

Paxil Pexeva 2008-2013 082613.xls 

Bates Numbered Documents 

AZPI 001-786 

AZPI 000100 

AZPI 000101 

AZPI 000151 

AZPI 000399 

AZPI 000530 

Articles 

Caves RE, Whinston MD, Hurwitz M, Pakes A, Temin P (1991), “Patent Expiration, Entry, and 

Competition in the U.S. Pharmaceutical Industry," Brookings Papers on Economic Activity; 

Microeconomics, 1991. 

Grabowski H, Long G, Mortimer R.'"Implementation of the Biosimilar Pathway: Economic and 

Policy Issues," Seton Hall Law Review, vol (41) 2. 

Grabowski HG, Vernon JM (1992). “Brand Loyalty, Entry, and Price Competition in 

Pharmaceuticals after the 1984 Drug Act," Journal of Law and Economics, 35. 

Hollis A (2002), “The Importance of Being First: Evidence from Canadian Generic 

Pharmaceuticals,” Health Economics, 11. 

“Pfizer buys right to OTC heartburn drug Nexium,” Yahoo Finance, August 13, 2012; 

http://finance.yahoo.com/news/pfizer-buys-rights-otc-heartburn-220241928.html 

“Synthon Pharmaceuticals’ PEXEVA Brings Big Savings to SSRI Market,” BioSpace, March 

18, 2004; http://www.biospace.com/News/l-pexeva-brings-big-savings-to-ssrimarket/15489920/So 

http://articles.economictimes.indiatimes.com/2007-07-17/news/28490329_1_lupin-tabletsmanaging-director-kamal-sharma 

http://osteoporosis.emedtv.com/fortical/generic-fortical.html 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 38 of 45 PageID: 16400
Exhibit 2: Materials Considered 

3 

http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=021153&Product

_No=001&table1=OB_Rx 

http://www.businesswire.com/news/home/20050816005531/en/Upsher-Smith-launches-ForticalNasal-Spray-postmenopausal-osteoporosis 

http://www.cedrugstorenews.com/userapp/lessons/page_view_ui.cfm?lessonuid=&pageid=D5B9

DCC03556C28694B51161244B36F9 

http://www.fda.gov/drugs/developmentapprovalprocess/ucm079068.htm 

http://www.lachmanconsultants.com/the-505b2-pathway-is-alive-and-well-first-south-koreannda-drug-product-approved.asp 

http://www.law360.com/articles/1019/pfizer-sues-dr-reddy-s-over-anda-for-norvasc-generic 

http://www.law360.com/articles/263/fda-approval-expected-to-set-off-legal-battle 

http://www.law360.com/articles/4421/pfizer-and-mylan-back-to-court-in-lengthy-dispute 

http://www.law360.com/articles/5031/court-upholds-pfizer-patent-for-norvasc 

http://www.law360.com/articles/53055/astrazeneca-ranbaxy-settle-nexium-patent-dispute 

http://www.law360.com/articles/919/fda-to-review-approval-of-norvasc-generic-as-505-b-2-

gateway-is-tested-in-court 

http://www.prnewswire.com/news-releases/ranbaxy-and-astrazeneca-reach-agreement-inesomeprazole-patent-litigation-57428867.html 

http://www.rediff.com/money/2003/nov/04drl.htm 

http://www.rxtimes.com/over-the-counter-nexium/ 

http://www.sharecare.com/health/calcium-regulator/miacalcin-the-same-asfortical;jsessionid=ACD0459D7D2A5E8FFF62B1BC3559215C 

http://www.theguardian.com/business/marketforceslive/2010/jan/07/astrazeneca 

http://www.wikinvest.com/stock/Pfizer_(PFE)/Norvasc_Amlodipine 

Declarations 

Declaration of Maureen Japha and Exhibits 

Declaration of Nimish Vakil and Exhibits 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 39 of 45 PageID: 16401
Exhibit 2: Materials Considered 

4 

Declaration of Robert Maresca 

Declaration of Robert Navarro and Exhibits 

Interviews 

Interview with Dr. Robert Hardi 

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 40 of 45 PageID: 16402
Economists Incorporated

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 41 of 45 PageID: 16403
Exhibit 4

Economists Incorporated

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 42 of 45 PageID: 16404
Exhibit 5

Economists Incorporated

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 43 of 45 PageID: 16405
Exhibit 6

Economists Incorporated

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 44 of 45 PageID: 16406
Exhibit 7

Economists Incorporated

Case 3:11-cv-00760-JAP-TJB Document 390-1 Filed 12/06/13 Page 45 of 45 PageID: 16407